These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37163883)

  • 21. Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.
    Bauer M; McIntyre RS; Szamosi J; Eriksson H
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1755-65. PubMed ID: 23672772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of repeated transcranial direct current stimulation on sleep quality and depression symptoms in patients with major depression and insomnia.
    Zhou Q; Yu C; Yu H; Zhang Y; Liu Z; Hu Z; Yuan TF; Zhou D
    Sleep Med; 2020 Jun; 70():17-26. PubMed ID: 32179428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis.
    Liguori C; Ferini-Strambi L; Izzi F; Mari L; Manfredi N; D'Elia A; Mercuri NB; Placidi F
    Br J Clin Pharmacol; 2019 Jan; 85(1):240-244. PubMed ID: 30328132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
    Nierenberg AA; Husain MM; Trivedi MH; Fava M; Warden D; Wisniewski SR; Miyahara S; Rush AJ
    Psychol Med; 2010 Jan; 40(1):41-50. PubMed ID: 19460188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study.
    Dichtel LE; Nyer M; Dording C; Fisher LB; Cusin C; Shapero BG; Pedrelli P; Kimball AS; Rao EM; Mischoulon D; Fava M; Miller KK
    J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32558402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
    Trivedi MH; Bandelow B; Demyttenaere K; Papakostas GI; Szamosi J; Earley W; Eriksson H
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1733-44. PubMed ID: 23673347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focusing on insomnia symptoms to better understand depression: A STAR*D report.
    Mason BL; Davidov A; Minhajuddin A; Trivedi MH
    J Affect Disord; 2020 Jan; 260():183-186. PubMed ID: 31499373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression.
    Snyder E; Cai B; DeMuro C; Morrison MF; Ball W
    J Clin Sleep Med; 2018 Nov; 14(11):1849-1857. PubMed ID: 30373688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidance on the conversion of the Chinese versions of the Quick Inventory of Depressive Symptomatology-Self-Report (C-QIDS-SR) and the Montgomery-Asberg Scale (C-MADRS) in Chinese patients with major depression.
    Liu J; Xiang YT; Lei H; Wang Q; Wang G; Ungvari GS; Morris DW; Zhu XZ; Lai KY; Zhong BL; Wong SY; Zhang L; Zhang Q; Zou YC; Xiao L; Zhao Q; Li Y; Wu J; Zhang GF; Chiu HF
    J Affect Disord; 2014 Jan; 152-154():530-3. PubMed ID: 24144585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients.
    McCall WV; Lisanby SH; Rosenquist PB; Dooley M; Husain MM; Knapp RG; Petrides G; Rudorfer MV; Young RC; McClintock SM; Mueller M; Prudic J; Greenberg RM; Weiner RD; Bailine SH; Riley MA; McCloud L; Kellner CH;
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 28742292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder.
    Carney CE; Segal ZV; Edinger JD; Krystal AD
    J Clin Psychiatry; 2007 Feb; 68(2):254-60. PubMed ID: 17335324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
    N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating insomnia in depression: Insomnia related factors predict long-term depression trajectories.
    Bei B; Asarnow LD; Krystal A; Edinger JD; Buysse DJ; Manber R
    J Consult Clin Psychol; 2018 Mar; 86(3):282-293. PubMed ID: 29504795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial.
    Carney CE; Edinger JD; Kuchibhatla M; Lachowski AM; Bogouslavsky O; Krystal AD; Shapiro CM
    Sleep; 2017 Apr; 40(4):. PubMed ID: 28199710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insomnia severity is an indicator of suicidal ideation during a depression clinical trial.
    McCall WV; Blocker JN; D'Agostino R; Kimball J; Boggs N; Lasater B; Rosenquist PB
    Sleep Med; 2010 Oct; 11(9):822-7. PubMed ID: 20478741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.